Composition containing melittin for inhibiting tumor-associated M2 macrophages

Item Number: 648
Industry: Therapeutic
Category: Oncology
Development Stage: Early Stage
Organisation Type: University
Country: South Korea
Patent: PCT
Business Opportunity: Out-Licensing, Technology Transfer, Collaboration R&D


The present invention relates to a composition comprising melittin for suppressing tumor progression through inhibition of angiogenesis by selectively inhibiting M2-like tumor associated macrophages (TAM) without inhibiting M1 macrophage function.

Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it